American Kidney Fund: APOL-1 Mediated Kidney Disease (AMKD) Webinar
- Registration Closed
Already registered?
Log in now.
This webinar is intended for all members of the Alpha Phi Alpha Fraternity, Incorporated.
Dr. Josiah Petersen
MD,PhD, Medical Director, Clinical Development and Translational Medicine
Vertex Pharmaceuticals
"Josiah Petersen, MD, PhD is an Associate Medical Director in Clinical Development and Translational Medicine at Vertex Pharmaceuticals. Prior to joining Vertex, Dr. Petersen was a Clinical Assistant Professor of Pediatrics at Mount Sinai Health System in New York. He attended medical school at the University of Pennsylvania and completed Pediatrics Residency at the University of Washington/Seattle Children’s Hospital.Dr. Patrick Gee graduated from the American University School of Public Affairs in 2012 with a Doctor of Philosophy in Justice, Law, and Criminology. In April 2013, he was diagnosed with Stage 3b End-Stage Kidney Disease (ESKD) and, after living as a Peritoneal and Hemodialysis patient due to Diabetic Kidney Disease, received a kidney transplant on April 21, 2017; following several complications, his new kidney began functioning on the 47th day post-transplant. A retired Major and Chief of Security from the Virginia Department of Corrections, Dr. Gee now serves as the Founder and CEHD of iAdvocate, Inc., a faith-based health and wellness nonprofit, and as an Ordained Minister at Mountain Movers Ministry in Richmond, VA. As a Patient Representative for the Diabetes Kidney Disease Collaborative Task Force and an advocate for individuals living with chronic kidney disease and related conditions such as diabetes, cardiovascular disease, hypertension, and obesity, Dr. Gee draws on his personal experiences to teach, coach, mentor, and educate others on effective disease management while championing equitable healthcare access for underserved, undervalued, and disenfranchised communities of color. His guiding mantra is, “I am the Voice for the Voiceless and the Face for the Faceless in the fight against kidney disease.”"
Key:
American Kidney Fund - APOL-1 Mediated Kidney Disease (AMKD) Webinar
11/19/2025 at 6:00 PM (EST) | 90 minutes
11/19/2025 at 6:00 PM (EST) | 90 minutes
Join Alpha Phi Alpha Fraternity, Inc., the American Kidney Fund (AKF), and Vertex Pharmaceuticals for an engaging discussion on the impact of chronic kidney disease (CKD) and APOL1-Mediated Kidney Disease (AMKD) on communities of color. This session will explore prevention, management, and opportunities for Black Greek Letter Organizations to advance kidney health awareness and health equity.
